GLP-1 drugs, such as Ozempic and Wegovy, may slightly increase the risk of osteoporosis, gout, and the rare metabolic bone disease osteomalacia, a recent study suggests.

Overall, the findings reinforce the Mediterranean diet as a practical and sustainable approach to healthy aging. In addition to its well-known benefits for heart health and metabolism, this eating ...

Adults with osteoporosis who receive denosumab vs bisphosphonates may have a lower long-term risk of developing knee osteoarthritis.

The study population saw noted payoff when they paired this trending apparel with another crucial activity.

A Mediterranean diet can significantly lower the risk of hip and overall fractures, according to a major new review from the ...

New research suggests GLP-1 drugs may increase the risk of bone and tendon injuries and other conditions, including ...

As an internal and functional medicine physician, Dr Robin Berzin was well versed in healthy aging for women. Then she was ...

A new study suggests GLP-1 drugs like Ozempic and Wegovy may raise fracture risk by 11% in adults 65 and older with Type 2 diabetes compared to other diabetes medications.

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

GLP-1s are linked to a higher risk for osteoporosis, gout, and osteomalacia in people with type 2 diabetes and obesity, new research suggests, though an additional study also points to better ...

People who take GLP-1 medications for several years may face a higher risk of developing osteoporosis, gout, and osteomalacia, according to new research presented Monday at the an ...

Women who start early menopausal hormone therapy after menopause have a lower risk for osteoporosis over a 5-year period, ...